Patent Office Rejects Abbot’s Application on HIV Drug Patent Office Rejects Abbot’s Application on HIV Drug – I-MAK

Patent Office Rejects Abbot’s Application on HIV Drug

4 Jan 2011

In what is seen as a New Year’s gift of sorts to people living with HIV/AIDS, the Indian Patent office has rejected Abbott’s patent application on its heat-stable version of the Lopinavir/Ritonavir drug. The Hindu -Business Line

Partner with us now to build
a more just and equitable
medicine system for all.